Stock Information
MapLight Therapeutics Inc (MPLT)
Ticker Symbol: MPLT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,551.90 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.5995
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: N/A%
Latest News
-
UBS Maintains Buy on MapLight Therapeutics, Raises Price Target to $52
Tue, Jul 21, 2026 2:32 PM
-
BMO Capital Initiates Coverage On MapLight Therapeutics with Outperform Rating, Announces Price Target of $46
Tue, Jul 21, 2026 6:03 AM
Key Financials
Financial data not available